Abstract:

In the present study, we aimed to assess the effect of combined estrogen cream on young girls’ labial adhesions, and to identify the possible factors affecting the treatment outcome. We retrospectively included 123 children with labial adhesions. Variables were collected, including treatment outcomes, conjugated estrogen usage, and dosage, whether it was combined with manual or surgical separation, whether to use erythromycin, and whether to be accompanied with vulvitis. Chi-square test, Fisher’s exact test, and t-test were used to analyze the correlation between influencing factors and treatment outcome in univariate analysis. We used logistic regression analysis to explore the key influencing factors. The use of conjugated estrogen in combination with manual or surgical separation (P = 0.001), and the degree of labial adhesions (P = 0.011) had significant effects on the final treatment outcome. The frequency of conjugated estrogen treatment, whether erythromycin was used in combination during treatment, and whether the children were accompanied by vulvitis had no significant effect on the treatment outcome (P > 0.05). After the logistic regression, we found that whether it was combined with manual or surgical separation (P = 0.000, OR = 0.078, 95% CI = 0.030–0.203), and the degree of labial adhesions in children (P = 0.003, OR = 5.324, 95% CI = 1.767–16.041) were independently related to the effect of conjugated estrogen treatment. The therapeutic effect of conjugated estrogen alone was better for mild adhesion. However, severe adhesions need to consider with manual or surgical separation in combination with conjugated estrogen treatment. It is not recommended to combine erythromycin with routine clinical treatment. Conjugated estrogen once a day can also achieve a good therapeutic effect.

Key words: Combined estrogen, Labial adhesion, Pediatrics &, gynecology clinic, Influencing factors